| 产品详情 |
| Edit |   |
| Product Name | TNFSF-15, Recombinant, Human (VEGI, TL1, Vascular Endothelial Growth Inhibitor, TNFSF, TNFSF-14) |
| Description | Purity ~95% (SDS-PAGE, HPLC). VEGI (Vascular Endothelial Growth Inhibitor) is a member of the tumor necrosis factor family. VEGI is predominantly an endothelial cell-specific gene, and recombinant VEGI is a potent inhibitor of endothelial cell proliferation, angiogenesis and tumor growth. VEGI exerts two activities of endothelial cells: early Gl arrest of G0/G1-cells responding to growth stimuli, and programmed cell death. VEGI is also able to regulate the expression of several important genes involved in angiogenesis. Source: Recombinant protein corresponding to 192aa polypeptide chains from human TNFSF-15, expressed in E. coli. Molecular Weight: ~21.8kD Biological Activity: The ED50, as determined by the dose-dependent inhibition of the proliferation of HUVEC, is <5ug/ml. Endotoxin: <0.1ng/ug |
| Size | 10ug |
| Concentration | n/a |
| Applications | n/a |
| Other Names | Vascular Endothelial Growth Inhibitor, TNFSF, TNFSF-14 |
| Gene, Accession, CAS # | TNFSF15, Gene ID: 41019336, Accession: AAR98573 |
| Catalog # | 220343 |
| Price | |
| Order / More Info | TNFSF-15, Recombinant, Human (VEGI, TL1, Vascular Endothelial Growth Inhibitor, TNFSF, TNFSF-14) from UNITED STATES BIOLOGICAL |
| Product Specific References | n/a |
| 产品资料 |
|
|